American Renal Associates (ARA) is Initiated by Wells Fargo to Outperform

American Renal Associates (ARA) was Initiated by Wells Fargo to “Outperform”. Wells Fargo advised their investors in a research report released on May 16, 2016.

Many Wall Street Analysts have commented on American Renal Associates. American Renal Associates was Initiated by Goldman to “Neutral” on May 16, 2016. American Renal Associates was Initiated by Sun Trust Rbsn Humphrey to “Buy” on May 16, 2016.

In a different news, on Apr 27, 2016, Syed T Kamal (PRESIDENT) purchased 500 shares at $22.00 per share price. According to the SEC, on Apr 27, 2016, Michael Ray Costa (VP, GC AND SECRETARY) purchased 370 shares at $22.00 per share price. On Apr 27, 2016, Joseph A Carlucci (CEO) purchased 500 shares at $22.00 per share price, according to the Form-4 filing with the securities and exchange commission.

American Renal Associates

Leave a Reply

American Renal Associates - Is it time to Sell?

Top Brokerage Firms are advising their investors on American Renal Associates. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.